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Background: Lack of timely recognition and neuroimaging may be a barrier to reperfu-
sion efforts in acute spinal cord infarction.
Methods: We performed a retrospective study of patients diagnosed with acute 
non-surgical spinal cord infarction at our tertiary academic center from 2001 to 2015. 
We studied parameters associated with time from symptom onset to initial hospital 
presentation and magnetic resonance imaging (MRI) of the spinal cord.
results: We identified 39 patients among whom anterior spinal artery syndrome was 
the most frequent presentation (87.2%) and atherosclerosis the most common etiology 
(56.4%). Nearly, half of the patients presented to the emergency department on the 
same day of symptom onset (48.7%) but only nine (23.1%) within the first 6 h. Average 
time from symptom onset to spinal cord MRI was 3.2 days. We could not identify clinical, 
radiological, or outcome patterns associated with early vs. delayed presentation and 
imaging.
Discussion: Our study found a time lag from symptom onset to hospital presentation 
and spinal cord MRI in patients with acute spinal cord infarction. These findings point at 
low clinical suspicion of spinal cord syndromes and limited recognition as a potentially 
treatable medical emergency.
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inTrODUcTiOn
Acute spinal cord infarction is a rare disorder, which accounts for only 8% of all myelopathies and 
not more than 1% of all strokes (1). The condition is provoked by acute disruption of the spinal cord 
blood supply and results in neurological deficits linked to the supplied vascular territory (2). In the 
majority of reported patient series, 40–60% of patients had initial American Spinal Cord Injury 
Association (ASIA) Impairment Scale Grades A and B and a similar proportion remains wheelchair 
dependent on follow-up several years later (3, 4). Further, the most recent long-term follow-up 
studies reported a 5-year mortality rate of 21–23% (5, 6).
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Two major pathophysiological mechanisms of action can be 
distinguished for spinal cord infarction. Radicular artery terri-
tory infarcts are caused by occlusion of the anterior or posterior 
artery and central and transverse infarcts are the consequence of 
systemic hypoperfusion. The main causes of spinal cord infarc-
tion are aortic interventions and pathologies, which constitute 
around two-thirds of the cases (4). The non-surgical etiologies are 
dominated by atherosclerosis, followed by cardiac and arterio-
arterial embolism, global hypoxia, infection, hypercoagulable 
state, and vasculitis (1, 7). In 20–30% of the patients, the etiology 
remains unclear. The clinical spectrum of spinal cord infarction 
is broad and ranges from complete or incomplete spinal cord 
dysfunction with various degrees of sensorimotor and autonomic 
disturbances (8). In contrast to cerebral ischemic stroke, many 
patients with spinal cord infarcts suffer from pain, which is 
commonly located at the level of the spinal cord lesion. Further, 
symptoms often develop slower than in supratentorial ischemic 
stroke, sometimes taking up to several hours before reaching the 
plateau (9).
Stroke is a neurological emergency. The pressure for rapid 
stroke recognition and presentation to the emergency depart-
ment (ED) is largely driven by the proven efficacy of systemic 
thrombolysis for cerebral ischemic stroke. Indeed, tissue plasmi-
nogen activator (t-PA) is an effective therapy for ischemic stroke 
involving both anterior and posterior circulations within the 
4.5 h timeframe (10). More recently, a few case reports delivered 
insights to feasibility and both potential safety and efficacy of t-PA 
administration in acute spinal cord infarction (11–15). A timely 
diagnosis is a pre-requisite to allow administration of t-PA more 
frequently in patients with spinal cord infarction. For cerebral 
ischemic stroke, numerous studies examined barriers for the 
time from symptom onset to arrival at the ED, neuroimaging, 
administration of t-PA, and benefit for the treatment at a special-
ized stroke unit (16, 17).
Here, we characterized the spectrum of clinical manifestations 
and radiological presentations of non-surgical spinal cord infarc-
tion and studied potential determinants of pre- and in-hospital 
delays. Spinal cord infarction accounts only for a small group 
of ischemic strokes and is not widely known for the spectrum 
of clinical symptoms, potential treatability, and poor prognosis. 
Thus, we hypothesized that there are barriers for translating the 
established standards of care for acute cerebral ischemic stroke to 
spinal cord infarction.
sUBJecTs anD MeThODs
Patient selection
We performed a retrospective study of patients treated at a ter-
tiary care center from January 2001 to July 2015.
Patients with spinal cord infarction were identified from the 
hospital database by using following search terms (in German): 
spinal cord ischemia, spinal cord infarction, ischemic myelopa-
thy, and non-compressive myelopathy.
Thirty-nine patients fulfilled the diagnostic criteria that were
 (a) acute or subacute (delay from onset to maximum clinical 
intensity up to 72 h) spinal cord syndrome,
 (b) no plausible alternative explanation based on extensive clini-
cal workup,
 (c) radiological investigations with magnetic resonance imaging 
(MRI) of the spinal cord within 10 days from symptom onset.
The excluded patients had extrinsic spinal cord compres-
sion, spinal arterio-venous malformation, systemic and demy-
elinating disease, and paraneoplastic syndromes. One patient 
with posterior cord infarction was reported in a previous case 
study (18).
clinical and Paraclinical Workup
Patients underwent standard diagnostic pathways for stroke, 
which included laboratory testing, evaluation of cardiovascular 
risk factors, and imaging. When in doubt of the diagnosis, a 
spinal tap was performed and analyzed for opening pressure, 
cell count, glucose, protein levels, lactate, hem-derived pigments, 
oligoclonal bands, immune electrophoresis, and the presence 
of blood–brain barrier dysfunction. The laboratory workup 
was amended with testing for autoimmune and paraneoplastic 
diseases, infections such as neurotropic viruses, HIV, Lyme bor-
reliosis, and Treponema pallidum. Spinal MRI (Philips MR 1.5 T 
until 2007 and later Philips 3.0 T) was performed at least once 
in all patients. The patients were screened for aortic or vertebral 
artery pathology based on the level of the spinal cord syndrome. 
Standard transthoracic cardiac sonography was performed in all 
patients.
analysis of Demographics, etiology, 
clinical Features, and Outcome
We studied demographics (age, sex), clinical symptoms at onset 
(acute pain in the neck, back, shoulder, chest, abdomen or head, 
or radicular pain), motor deficits at the ED (motor functions 
of the worst affected extremity, assessed by Medical Research 
Council scales), sensory level (the most caudal segment of the 
spinal cord with normal bilateral sensory functions), joint posi-
tion sense and vibration testing, and urine retention. Further, we 
explored whether acute respiratory failure developed or not and 
mechanical ventilator support was required.
When determining the lesion level we used combined clinical 
and radiological findings. A follow-up scan was performed if the 
initial one was negative, or when the clinical course required re-
evaluation. We reviewed sagittal T1- and T2-weighted images, 
axial T2-weighted images at the suspected lesion level and 
diffusion-weighted imaging, if available. According to the clini-
cal features and MRI findings, patients were classified as having 
anterior spinal artery (ASA), posterior spinal artery, central 
cord, or transverse cord infarction. We graded the extent of 
spinal cord injury with the ASIA Impairment Scale, as reported 
previously (19).
The etiology was based on the criteria and classification pro-
posed by Nedeltchev et al. (9):
 (i) atherosclerosis: history or features of vascular disease or 
presence of >2 vascular risk factors,
 (ii) aortic pathologies: aortic aneurysms or dissections,
TaBle 1 | Demographics of 39 patients with non-surgical spinal cord 
infarction.
Parameter
Mean (SD) age (years) 67.8 (12.4)
Women, N (%) 19 (48.7)
Vascular risk factors, N (%)
Hypertension 25 (64.1)
Diabetes mellitus 12 (30.8)
Angina pectoris/peripheral arterial occlusive disease 6 (15.4)
History of stroke/transient ischemic attack 8 (20.5)
Hyperlipidemia 10 (25.6)
Possible etiology, N (%)
Atherosclerosis 22 (56.4)
Aortic pathology 4 (10.3)
Degenerative spinal disease 4 (10.3)
Cardiac embolism 2 (5.1)
Systemic hypotension 2 (5.1)
Iatrogenic 2 (5.1)
Unknown 3 (7.7)
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 (iii) degenerative spine disease at the level of the cord ischemia 
with the potential of radiculomedullary artery compression 
in patients without vascular risk factors,
 (iv) cardiac embolism defined as the presence of previously 
or newly established atrial fibrillation without concurrent 
etiologies,
 (v) systemic hypotension defined as an episode of mean arterial 
pressure below 50 mm Hg, and
 (vi) idiopathic.
The analysis of vascular risk factors included following 
parameters:
•	 hypertension (systolic blood pressure >140 mm Hg, diastolic 
blood pressure >90 mm Hg or both),
•	 diabetes mellitus (symptoms of diabetes plus fasting blood 
glucose >126 mg/dl or current use of hypoglycemic agents),
•	 hyperlipidemia (cholesterol normal range >200  mg/dl, 
triglyceride normal range >150 mg/dl, or current use of lip-
id-lowering drugs),
•	 atrial fibrillation (ECG or transthoracic echocardiogram),
•	 previous cerebral infarctions or transient ischemic attacks 
(TIAs) (clinical history and chart records),
•	 myocardial infarction (clinical history, chart records, and ECG),
•	 heart diseases (congestive heart failure, arrhythmia, heart 
valve disease),
•	 renal disease,
•	 family histories of cerebrovascular attacks, and
•	 cigarette smoking.
Aortic disorders, particularly aortic dissection, aneurysm, 
or atheroma, were evaluated non-invasively by transthoracic 
echocardiogram, computed tomography, or MRI. Diagnostic or 
therapeutic angiograms were evaluated. We assessed outcome 
according to medical records at discharge. The categories were 
in-hospital death or death within 3 months, walk without help 
at discharge, with help of another person, wheelchair dependent, 
or bedridden.
statistical analysis
We used χ2 test, with Yates correction or Fisher’s exact test, to com-
pare qualitative variables and the non-parametric Kruskal–Wallis 
test to compare quantitative variables. We performed statistics by 
using STATA SE 13.0 for Windows (StataCorp LP, TX, USA).
resUlTs
Demographics
The search for non-surgical cases of spinal cord infarction revealed 
39 patients, 20 were men (51.3%). Most patients were admitted 
within the last few years. While five patients were identified in the 
period from 2001 to 2005, this number increased to 11 from 2006 
to 2010 and eventually 23 cases within the last 4 years.
Median age was 69 years (range 44–90). Vascular risk factors 
were dominated by arterial hypertension (64.1%), the runner-up 
was diabetes (30.8%). One-fifth had a history of cerebral TIA 
or stroke. Atherosclerosis was the presumed etiology in 56.4% 
of cases. Further demographics, cardiovascular risk factors, 
distribution of etiologies, and comorbidities are outlined in 
Table 1.
clinical Findings and Presentation  
at the eD
Bilateral and unilateral anterior spinal artery syndromes were 
the most frequent clinical presentations (71.8 and 15.4%, 
respectively). ASIA B impairment was most frequent in bilateral 
anterior spinal artery syndromes (38.5%), a specific time course 
of clinical disturbances could not be identified when compared 
to the other syndromes.
A sensory level was found most commonly within thoracic 
dermatomes (46.1%). Pain history was unclear in 4 (10%) and 
not reported in 14. Pain preceded other symptoms in 17/21 
(73.9%) and developed in conjunction with other symptoms in 
the remaining 4. Pain persisted until transfer to rehabilitation in 
the majority. The localization of pain was usually in line with the 
spinal cord lesion on MRI. However, there was a discrepancy for 
pain and lesion level in six patients. Autonomic dysfunction was 
rare and reported only in two cases (5.4%) in terms of urinary 
incontinence. A detailed presentation of clinical findings is 
shown in Table 2.
One extreme outlier with ASIA Impairment Scale B was 
excluded for the analysis of time to hospital admission. The aver-
age time from symptom onset to ED presentation in 38 patients 
was 2.2  days (SD 4.1). There was no significant difference for 
patients with different ASIA Impairment Scales, as shown in 
Table 2.
We further examined the courses of 13 patients (33.3%), in 
whom the exact time (in minutes) from symptom onset to ED 
presentation was documented. Of them, four arrived at the ED 
later than 6 h after symptom onset. The affected spinal arterial 
territory (anterior or posterior), presumed etiology, presence of 
pain, and ASIA scores on admission were not associated with 
time from symptom onset to ED presentation (Table 5).
Only nine patients were seen in the ED within the “window 
of opportunity” of less than 6  h (23%). None of the patients 
TaBle 2 | clinical syndromes and time to emergency department (eD) 
presentation and spinal cord magnetic resonance imaging (Mri) of 39 
patients with non-surgical spinal cord infarction.
american spinal cord injury association 
impairment scale, N (%)
Parameter a B c D Total
Degree of impairment 
at presentation, N (%)
2 (5.1) 10 (25.6) 19 (48.7) 8 (20.5) 39 (100)
Neurological syndrome, N (%)
Anterior spinal artery 2 (5.1) 5 (12.8) 15 (38.5) 6 (15.4) 28 (71.8)
Anterior unilateral 0 2 (5.1) 2 (5.1) 2 (5.1) 6 (15.4)
Posterior unilateral 0 1 (2.6) 1 (2.6) 0 2 (5.1)
Central 0 1 (2.5) 0 0 1 (2.6)
Posterior syndrome 0 1 (2.6) 0 0 1 (2.6)
Complete spinal 
cord syndrome
0 0 1 (2.6) 0 1 (2.6)
Neurological level, N (%)
Cervical 0 3 (7.7) 3 (7.7) 1 (2.6) 7 (17.9)
Thoracic 1 (2.6) 5 (12.8) 10 (25.6) 2 (5.1) 18 (46.1)
Lumbosacral 0 0 1 (2.6) 0 1 (2.6)
Overlapping 1 (2.6) 2 (5.1) 5 (12.8) 5 (12.8) 13 (33.3)
Pain reported, N (%) 1 (2.6) 6 (15.4) 11 (28.2) 4 (10.3) 22 (56.4)
Autonomic 
disturbance, N (%)
0 0 2 (5.4) 0 2 (5.4)
Mean (SD) days to ED 
presentation
1.5 (2.1)a 0.6 (0.5)a 2.7 (4.5) 3.1 (5.4) 2.2 (4.1)a
Mean (SD) days from 
symptom onset to 
first MRI
1.5 (2.1) 5.7 (14.2) 1.7 (2.0) 4.6 (10.1) 3.2 (8.1)
Mean (SD) days from 
symptom onset to 
second MRI
– 7.0 (3.6) 10.2 (11.7) 6.5 (3.5) 8.6 (8.9)
aCalculation excluding one outlier.
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received t-PA. In this acute period, MRT was conclusive in only 
one patient (number 37 in Table 3). This patient had acute onset 
of pain in both shoulders accompanied with tetraparesis. MRI 
showed a T2-lesion from C2 to Th2 consistent with central spinal 
cord infarction. The sensory symptoms were mild and spinal tap 
revealed high protein values (85 mg/dl).
spinal cord Mri
All patients were examined with MRI of the spine; exact times 
were documented in 18 patients. Median time from admission to 
first MRI 4:59 h (inter-quartile range 2:10–11:20 h).
The entire spine was studied in 75% of the patients, and exclu-
sive examination of the cervical and thoracolumbar cord was 
performed in 18 and 7%, respectively. Further details are outlined 
in Tables 2 and 4. MRI lesions were not detected in four patients 
(10%) even with repeated spinal cord MRI, these were patients 
13, 14, 19, and 38. Spinal CT was performed in 17/39 (22.0%) and 
10 patients underwent conventional spinal angiography (25.6%). 
One patient had an occlusion of the Adamkiewicz artery (arteria 
radicularis magna).
The first T2-weighted spinal cord MRI was diagnostic in 
4/39 (10.3%) of patients, the gain was slightly higher with DWI 
(5/39, 12.8%). A second MRI of the spinal cord was performed 
in 29 patients (74.4%), and revealed a T2- and DWI lesion in 
10/29 (34.4%) and 4/29 (13.8%), respectively. A third MRI was 
performed in eight (20.5%). Mean time from symptom onset 
to MRI was 3.2  days (SD 8.1). A trend for an earlier spinal 
cord MRI was found for patients with pain (1.2 vs. 5.8 days, 
p = 0.087).
laboratory Findings
Workup for vasculitis and autoimmune disorders was performed 
in 21 (53.4%) patients and was negative in all of them. A spinal tap 
was performed in 10/39 (25.6%). Elevated protein concentration 
was found in eight (80%) and a pleocytosis was present in one. 
Fourteen patients were examined with somatosensory evoked 
potentials (35.9%) and 9/14 (64.2%) had central conduction 
deficits.
Outcomes
Four patients died, details of these patients are shown in Table 3. 
One patient died on day 6, the remaining more than 3 months 
after admission. One patient was able to walk without help (2.6%) 
at discharge, 2 with help of another person (12.8%), 15 (38.5%) 
were discharged in a wheelchair, and 5 (12.8%) were bedridden. 
For 13 patients (33.3%), the exact discharge status was unknown. 
ASIA score at symptom onset was not associated with the clinical 
status at discharge.
DiscUssiOn
This study characterized the clinical and radiological spectrum of 
non-surgical spinal cord infarction and analyzed potential bar-
riers to diagnosis and treatment. The retrospective chart review 
identified 39 patients from a tertiary care center over a period 
of 14 years with a diagnostic peak within the last 4 years. Nearly 
half of the patients presented on the same day of symptom onset 
(48.7%) but only nine (23%) within the first 6 h. Further substan-
tial time lags were identified for spinal cord MRI with average 
time to a first spinal MRI of 3.2 days. Discrimination of vascular 
and inflammatory diseases turned out to be challenging in some 
cases, and also required CSF testing and repeated MRI in a few 
cases. These findings point at low clinical suspicion of spinal cord 
syndromes and recognition as a potentially treatable medical 
emergency. Notably, we could not identify demographic, clinical, 
or radiological features associated with delays in ED presentation 
and spinal MRI.
Most infarcts present as an anterior cord syndrome, which 
results from vascular occlusion or hypoperfusion of the ASA ter-
ritory and its watershed area (20). In our cohort, the bilateral ASA 
territory was most frequently affected (72%). Previous studies of 
non-surgical spinal cord infarction with a similar patient number 
reported a frequency of 51–75% for anterior cord syndrome 
(8, 21, 22). Lesion localization in our study was thoracic cord in 
46% of patients and the distribution varies largely in the literature 
(39–75%) (9, 22). The common affection of the thoracic cord 
might be related to insufficient collaterals in this region and thus 
the thoracic cord spine being sensitive to systemic hypotension 
(4). The clinical outcome was unfavorable in about 50%. It needs 
to be acknowledged that our study is skewed toward an elderly 
population (67.8  years). Further, we only studied short-term 
TaBle 3 | clinical presentation and short-term outcome of 39 patients with non-surgical spinal cord infarction.
no. age gender Possible causes location of pain sensory 
level
american spinal cord injury 
association impairment scale 
grade
Mobility at 
discharge
in-hospital 
death
1 87 M Atherosclerosis Whole body Th12 B Not mobile
2 58 M Degenerative spinal disease Head and neck C3–Th4 D –
3 76 M Atherosclerosis Th11 C Not mobile
4 84 F Atherosclerosis C3–C7 C Not mobile
5 68 F Atherosclerosis Buttocks both sides Th12 D With help
6 63 M Atherosclerosis Th8 D –
7 70 M Atherosclerosis Upper abdomen C3 C Yes
8 72 F Iatrogen Th9 B –
9 84 M Cardiac embolism Th7 B Yes
10 54 F Degenerative spinal disease Neck with shoulders C6 B Wheelchair
11 75 M Aortic pathology Chest and back Th1 C Wheelchair
12 52 M Aortic pathology Th4 C With help
13 45 F Unknown Chest spine C2 C –
14 62 M Degenerative spinal disease Both scapulas to arms C5 D With help
15 52 F Atherosclerosis Left abdominal Th5 A –
16 69 F Atherosclerosis Lumbar Th12 C –
17 58 M Atherosclerosis Lumbar spine Th9 B –
18 75 F Aortic pathology Th11 D Wheelchair
19 68 M Atherosclerosis Left quadriceps Th9 D Wheelchair
20 70 F Atherosclerosis Th12 A Not mobile
21 82 F Systemic hypotension Th6 C Wheelchair
22 77 M Atherosclerosis Inguinal Th7 C With help
23 61 M Atherosclerosis Between scapula C4 D –
24 85 F Systemic hypotension Th12 B Yes
25 64 F Degenerative spinal disease Lumbar spine Th12 C Wheelchair
26 57 M Atherosclerosis Th9 C Wheelchair
27 90 F Atherosclerosis Th12 C –
28 64 F Atherosclerosis Both legs L1 B –
29 70 M Unknown Lumbar spine Th4 C –
30 70 M Cardiac embolism Th10 B Not mobile
31 45 F Idiopathic Both arms C5 C Wheelchair
32 61 F Atherosclerosis Neck both shoulders C3 B Wheelchair
33 79 M Atherosclerosis Th9 C –
34 70 M Atherosclerosis Neck both shoulders C2 C Wheelchair
35 84 F Atherosclerosis C4 D Wheelchair
36 57 F Atherosclerosis Th12 C Wheelchair
37 84 F Aortic pathology C5 B Alone Yesa
38 59 F Atherosclerosis Left leg Th6 C –
39 45 M Iatrogenic Th6 C Wheelchair
aThe patient died in hospital after transfer to internal medicine due to heart failure.
F, female; M, male; C, cervical; Th, thoracal; –, unknown.
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outcome and gradual improvement over up to a year can be 
observed (4, 5, 23).
Cerebral stroke is characterized by a sudden onset of clinical 
deficits. This contrasts the situation in spinal cord infarction, 
where symptoms are often preceded or accompanied by acute 
pain and develop over a longer period of time (21, 24). Indeed, 
in non-surgical spinal cord infarction the plateau of sensory, 
motor, and autonomic dysfunction ranges from minutes to more 
frequently several hours (8, 20). Patients with cerebral infarcts in 
comparable cohorts tended to be older have more cardiovascular 
risk factors and more frequently experience a TIA (24–26). 
Further, while a history of stroke or TIA is frequent in cerebral 
stroke, we corroborate previous studies that spinal cord TIAs are 
rare (8, 9, 22). In our series, vascular risk factors were present in 
a high proportion of patients and atherosclerosis was the most 
common etiology. Nowadays, patients, caregivers, and health care 
professionals are aware of clinical symptoms related to cerebral 
stroke and recognize time as a key issue for treatment. This aware-
ness can be taken as a result of media campaigns and structural 
adaptations within healthcare systems by defining stroke-like 
presentations as a medical emergency (27, 28). Our findings of a 
delayed presentation at the ED suggest that the clinical spectrum 
of non-surgical spinal cord infarction is less known in the public 
and potentially among primary care physicians. In our cohort, 
neither extent of motor disturbances, pain, nor other factors was 
associated with earlier hospital arrival. Occurrence of pain was 
frequent prior to the development of neurological deficits. The 
clinical presentation, however, might be misjudged as radicular 
nerve compression, cardiac emergency, or aortic pathology. 
The reported delays are unfortunate, as spinal cord infarction is 
associated with detrimental functional outcome (29). Further, 
timely admission to the stroke unit might be associated with 
TaBle 4 | spinal cord Mri findings of 39 patients with non-surgical spinal cord infarction.
no. Time from symptom onset 
to Mri (in days)
Mri level DWi positive on first 
Mri
T2 signal positive on 
first Mri
DWi positive on 
second Mri
spinal angiography
1 5 N/A No −
2 0 C3–Th4 No −
3 0 N/A No − No
4 41 C3–C7 Yes +
5 0 Th12–L1 No − Yes Negative
6 5 N/A No − No
7 4 C3–C7; Th1–Th11 No − No
8 1 Th9–conus −
9 2 Th7 No +
10 1 C6 −
11 0 Th1/Th4 No −
12 6 Th4–Th6 Yes −
13 0 C2–Th2 No − Yes Negative
14 2 C5–Th2 No +
15 0 Th5–Th8 Yes − Negative
16 7 Th12/conus No − Yes
17 N/A N/A +
18 3 N/A −
19 0 Th9/Th12 No −
20 0 Th12–L1 No −
21 Th6 −
22 0 Th7–conus No −
23 0 N/A + Negative
24 1 Th12 No −
25 0 Th12–L1 −
26 0 Th9/Th10 No +
27 1 Thoracic No −
28 0 N/A − Arteria radicularis magna 
occlusion
29 N/A N/A No + Negative
30 29 Th10/Th11 −
31 0 C5/C6 No − Negative
32 1 C3/C4 Yes + Negative
33 1 Th9–L1 No −
34 3 C2/C4 −
35 1 C4–C7 No +
36 0 Th12 No − Negative
37 0 C5, C6 Yes −
38 1 Th6/7 No – Negative
39 1 Th6–conus No + Yes
N/A, not available; C, cervical; Th, thoracal.
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better outcome and thrombolytic therapies appear to have a 
logical role in the management of spinal cord infarction (6, 29). 
Stroke unit care has been shown to be beneficial regardless of 
the stroke etiology following acute ischemic and hemorrhagic 
stroke (30). Beyond the established stroke unit standards of 
care, initiation of antiplatelet therapy or heparin would be the 
obvious consequence with the presence of vascular risk factors 
or potentially progressive etiologies of spinal cord infarction 
such as vertebral artery dissection (29). In traumatic spinal cord 
injury, higher blood pressure correlated with better neurological 
recovery (31). This observation backs the recommendation to 
raise the mean arterial pressure above 85–95 mm Hg for the ini-
tial 5–7 days in traumatic spinal cord injury. In the lack of study 
evidence and obvious pathophysiological benefits of improved 
spinal cord perfusion, this concept could be translated to spinal 
cord infarction (19, 20). Further, a lumbar drain that allows low-
ering of CSF pressure to 10–15 mm Hg to improve spinal cord 
perfusion in spinal cord ischemia may be considered (20, 32). 
The guidelines of the German Neurological Society have listed a 
lumbar drain for thoracic anterior spinal artery syndromes which 
occur during aortic or thoracic surgery. By contrast, the German 
expert panel concluded that there is not sufficient evidence to 
recommend thrombolysis or endovascular treatment options. 
Whether antiplatelet therapy leads to hemorrhagic complications 
in this context is unclear. Freedman and coworkers also suggest 
the usage of high-dose steroids in non-traumatic spinal cord 
infarction according to the traumatic spinal cord injury protocol 
within the first 3 h due to limited side-effects and lack of proven 
other treatment options (20). Anticonvulsants administered at 
therapeutic doses for the management of neuropathic pain were 
shown to enhance motor recovery after acute spinal cord injury 
(33). Notably, early administration (i.e., within 1  month) for 
gabapentinoids, such as pregabalin and gabapentin, was integral 
for enhanced recovery.
TaBle 5 | Time from symptom onset to presentation in 13 patients with 
non-surgical spinal cord infarction.
Within 6 h 
(N = 9)
after 6 h 
(N = 4)
χ2 p 
Value
Anterior spinal artery territory (N = 9) 77.9 50.0 1.000 0.317
Other arterial territories (N = 4) 22.2 50.0
Atherosclerotic etiology (N = 7) 55.6 50.0 0.034 0.853
Other etiologies of spinal cord 
infarction (N = 6)
44.4 50.0
Pain (N = 7) 44.4 75.0 1.040 0.308
No pain (N = 6) 55.6 25.0
American Spinal Cord Injury 
Association (ASIA) Impairment Scale 
Grades A–C (N = 11)
88.9 75.0 0.410 0.522
ASIA Impairment Scale Grade D 
(N = 2)
11.1 25.0
Percentages are shown for patients within and beyond 6 h from symptom onset.
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We found substantial time barriers to the realization of throm-
bolysis and admission to the stroke unit. On the one hand, there are 
difficulties of clinical recognition and unusual disease evolution 
due to the slow development of the plateau in contrast to cerebral 
infarction. On the other hand, it is unclear which examinations 
in addition to the workup for cerebral stroke are required to rule 
out potential contraindications. Obviously, an MRI of the entire 
spine with T2, DWI, and post-contrast T1 is required to evaluate 
other causes of myelopathy including intramedullary and extra- 
and intradural pathologies (25). However, the detection of a 
myelopathy on MRI is not specific for spinal cord infarction. 
Further, it is a key to rule out life-threatening contraindications 
of t-PA therapy and causes of spinal cord infarction including 
aortic dissection. The exclusion of metabolic, cardiac, and cer-
ebral pathologies requires additional diagnostic means such as 
CT scan of the brain, electrocardiogram, and laboratory testing. 
When resources are available, some authors also suggest spinal 
CT arteriography to visualize vessel occlusions and proceed 
with direct intra-arterial thrombolysis (12, 20). We identified 
significant delays from symptom onset to spinal cord imaging 
as another major obstacle to initiate systemic thrombolysis. Yet, 
whether a time window of 4.5 h or even beyond this period can 
be translated to spinal cord infarction remains unclear (34, 35). 
The few case reports available seem to confirm the safety profile 
within the 4.5 h time frame (11–14). Another issue is the fact that 
a T2/DWI mismatch concept is not established for spinal cord 
infarction and dynamics of lesion evolution are only scarcely 
known. T2-weighted imaging in spinal cord infarction may not 
visualize a lesion within the first 12–15 h (25). Treatment with 
t-PA in cerebral stroke is based on exclusion of contraindications 
and is established in the lack of a detectable brain lesion in the 
acute phase. This line of thought has yet to be extended to spinal 
cord infarction. Typical for bilateral anterior spinal cord infarc-
tion are hyperintense lesions on axial T2-imaging in the region 
of the anterior horns illustrating the “snake eye” or “owl’s eye” 
configuration. Lesions and pathologies on MRI, however, are not 
uniform and include a pencil-like lesion pattern on T2, various 
degrees of cord swelling, and enhancement on post-contrast 
T1 (25). Superiority of early lesion detection by DWI has been 
reported not only in cerebral stroke but also in spinal cord infarc-
tion (25, 36, 37). In our series, a lesion regardless of DWI or T2 
was present on initial imaging in 15.4% and we corroborated a 
slightly higher yield with DWI. The exact time course of lesion 
development remains to be elucidated. Treatment decision for 
t-PA or should be guided by clinical presence of a spinal cord 
syndrome, exclusion of contraindication, and adherence to the 
time window proposed for cerebral stroke.
The retrospective nature of the study, the number of patients 
with exact time of symptom onset, and scarce documentation of 
clinical evolution are limitations of the study. Further, this study 
reports a single and tertiary care center experience and awaits 
confirmation from other settings and countries.
cOnclUsiOn
We confirm the notion that early hospital presentation and 
timely neuroimaging of patients with spinal cord infarction is 
rare. With regard to opening the time window for thrombolysis 
and stroke unit care for more patients with spinal cord infarc-
tion, we could not identify demographic, clinical, or radiological 
characteristics, which determine time delays for the diagnosis 
of spinal cord infarction. There is an urgent need to raise the 
awareness of this rare syndrome in order to augment the rate 
of treatment interventions directed at reperfusion. Even if 
thrombolysis cannot be performed due to contraindications or 
ED presentation beyond the time frame, stroke unit care might 
positively affect outcome as for cerebral stroke. Double-blinded 
randomized studies for spinal cord infarction cannot be expected 
within the next years. Prospective databases of patients treated 
with t-PA according to a uniform protocol, which adheres to the 
established standards, might shed further light to the efficacy 
and safety of this rare but still devastating cause of permanent 
neurological disability.
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